APA (7th ed.) Citation

Waissi, W., Burckel, H., Nicol, A., Larderet, G., & Noel, G. (2018). Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells. International Journal of Radiation Oncology, Biology, Physics, 102, e160. https://doi.org/10.1016/j.ijrobp.2018.07.616

Chicago Style (17th ed.) Citation

Waissi, W., H. Burckel, A. Nicol, G. Larderet, and G. Noel. "Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells." International Journal of Radiation Oncology, Biology, Physics 102 (2018): e160. https://doi.org/10.1016/j.ijrobp.2018.07.616.

MLA (9th ed.) Citation

Waissi, W., et al. "Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells." International Journal of Radiation Oncology, Biology, Physics, vol. 102, 2018, p. e160, https://doi.org/10.1016/j.ijrobp.2018.07.616.